Jack Lief
2013
In 2013, Jack Lief earned a total compensation of $4M as Former President, Chief Executive Officer and Director at Arena Pharmaceuticals, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $388,781 |
|---|---|
| Option Awards | $706,122 |
| Salary | $725,000 |
| Stock Awards | $2,131,200 |
| Other | $16,041 |
| Total | $3,967,144 |
Lief received $2.1M in stock awards, accounting for 54% of the total pay in 2013.
Lief also received $388.8K in non-equity incentive plan, $706.1K in option awards, $725K in salary and $16K in other compensation.
Rankings
In 2013, Jack Lief's compensation ranked 1,778th out of 12,286 executives tracked by ExecPay. In other words, Lief earned more than 85.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,778 out of 12,286 | 86th |
Division Manufacturing | 578 out of 4,612 | 88th |
Major group Chemicals And Allied Products | 154 out of 1,462 | 90th |
Industry group Drugs | 104 out of 1,156 | 91st |
Industry Pharmaceutical Preparations | 90 out of 890 | 90th |
Source: SEC filing on April 28, 2016.
Lief's colleagues
We found five more compensation records of executives who worked with Jack Lief at Arena Pharmaceuticals in 2013.
2013
Dominic Behan
Arena Pharmaceuticals
Chief Scientific Officer
2013
Steven Spector
Arena Pharmaceuticals
General Counsel
2013
William Shanahan
Arena Pharmaceuticals
Chief Medical Officer
2013
Robert Hoffman
Arena Pharmaceuticals
Chief Financial Officer
2013
Harry Hixson
Arena Pharmaceuticals